When hormone therapy sneaks under your nose

Menopause

Volumn 15, Issue 2, 2008, Pages 215-216

  Simomcini, Tommaso ^a   Mannella, Paolo ^a   Genazzani, Andrea R ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; GESTAGEN; HORMONE BINDING PROTEIN; NORETHISTERONE ACETATE; SEX HORMONE;

AGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE COURSE; DRUG DOSAGE FORM COMPARISON; EDITORIAL; HEMOSTASIS; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE; MORBIDITY; MORTALITY; SEX DIFFERENCE;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; AGING; ESTROGENS; FEMALE; HEMOSTASIS; HUMANS; MENOPAUSE; THROMBOSIS;

EID: 40449097304     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318162cb16     Document Type: Editorial

References (21)

1. Utian WH. NIH and WHI-time for a mea culpa and steps beyond. Menopause 2007;14:1056-1059.
2. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.
3. Deleted in proof.
4. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.
5. Simoncini T, Genazzani AR. Direct vascular effects of estrogens and selective estrogen receptor modulators. Curr Opin Obstet Gynecol 2000;12:181-187.
6. Fu XD, Simoncini T. Non-genomic sex steroid actions in the vascular system. Semin Reprod Med 2007;25:178-186.
7. Grodstein F, Stampfer M, Manson J, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461.
8. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1769-1775.
9. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613.
10. Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000;343:522-529.
11. The Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
12. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.
13. Genazzani AR, Gambacciani M, Simoncini T. The latest elaboration of the Women's Health Initiative data on hormone replacement therapy and cardiovascular disease in postmenopausal women. Gynecol Endocrinol 2007;23:183-185.
14. Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007;115:840-845.
15. Kuhl H. Pharmacokinetics of oral contraceptive steroids and drug interaction: introduction. Am J Obstet Gynecol 1990;163(6 Pt 2):2113.
16. De Lignieres B, Basdevant A, Thomas G, et al. Biological effects of estradiol-17β in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab 1986;62:536-541.
17. Genazzani AR, Gambacciani M. Cardiovascular disease and hormone replacement therapy: Position paper from the International Menopause Society Expert Workshop. Climacteric 2000;3:233-240.
18. Scarabin PY, Oger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003;362:428-432.
19. Kenemans P, Genazzani AR, Palacios S, et al. Pulsed estrogen exposure selectively modulates tissue response: a hypothesis. Gynecol Endocrinol 2004;18:159-164.
20. Simoncini T, Fornari L, Mannella P, et al. Differential estrogen signaling in endothelial cells upon pulsed or continuous administration. Maturitas 2005;50:247-258.
21. Hemelaar M, Kenemans P, Hack CE, et al. Hemostatic markers in healthy postmenopausal women during intranasal and oral hormone therapy: a randomized trial. Menopause 2008;15:248-255.